who manufactures glp 1 drugs Medicare GLP-1 Drug Coverage 2025’s Breakthrough GLP-1 Obesity Treatments:
Description
The trial randomized and dosed 94 people for the first 12 weeks of study
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study
Metformin at $7 per month produces roughly 3% weight loss, or about $2.33 per percentage point
The system never gets a meaningful break from stimulation
Source: Fact MR (FMR) analysis, based on proprietary forecasting model and primary research
doi: 10.1111/j.1365-2826.2012.02364.x, 85 LaFataE
